{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:40:48Z","timestamp":1793083248177,"version":"4.5.0"},"reference-count":212,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009160","name":"University of Toulouse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"R\u00e9gion-Occitanie-Midi Pyr\u00e9n\u00e9es"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["FEDER-HUM-OCC005443"],"award-info":[{"award-number":["FEDER-HUM-OCC005443"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ageing plays a critical role in the deterioration of artery function and structure, and clearly represents the first cardiovascular (CV) risk factor in men but also in women. Coronary and cerebral arteries are particularly prone to atheroma, and the tissues they perfuse are particularly vulnerable to ischaemia. In both sexes, the age-related decrease in sex hormones (menopause and andropause) has deleterious effects on CV health. The extent to which hormonal supplementation can limit the CV risks increased by ageing remains controversial. The Women Health Initiative study, the main clinical intervention designed to evaluate the benefit\/risk ratio of hormone treatment after menopause, revealed in 2002 an unexpected increase in CV events in aged women (&amp;gt;70 years) given estrogens plus a peculiar synthetic progestin medroxyprogesterone acetate, whereas estrogens alone were not harmful but even protective in younger women (&amp;lt;60 years). This pointed out the double problem of the progestin (now natural progesterone is preferred) and of the age. The clinical situation is not yet clear for testosterone and CV disease in men. Related to these questions, we will analyse and summarize: (i) the importance of the doses and concentrations of estrogens and testosterone, both in humans and in experimental models, allowing to define relevant\/physiological or pharmacological actions of sex hormones in respect to their medical modulations in practice; (ii) the main clinical studies conducted with estrogens or androgens, in terms of CV protection and the impact of age on these effects; (iii) the mechanisms underlying these actions; (iv) the gender-affirming hormone therapy, as these sex hormones are the cornerstone of gender transition care management.<\/jats:p>","DOI":"10.1093\/cvr\/cvaf086","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:51:07Z","timestamp":1747817467000},"page":"1551-1565","source":"Crossref","is-referenced-by-count":19,"title":["From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing"],"prefix":"10.1093","volume":"121","author":[{"given":"Coralie","family":"Fontaine","sequence":"first","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gosset","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Davezac","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"Buscato","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Grouthier","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Biology of CV Diseases, UMR 1034 \u00a0 Pessac F-33600 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5287-1540","authenticated-orcid":false,"given":"Marie-Ange","family":"Renault","sequence":"additional","affiliation":[{"name":"University of Bordeaux, Inserm, Biology of CV Diseases, UMR 1034 \u00a0 Pessac F-33600 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Henrion","sequence":"additional","affiliation":[{"name":"University of Angers, MITOVASC department, CarMe Team, Inserm U1083, UMR CNRS 6015 , Angers ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tr\u00e9molli\u00e8res","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-5371","authenticated-orcid":false,"given":"Michael","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Inserm U1195, University Paris-Saclay , Le Kremlin-Bic\u00eatre ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Lenfant","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Arnal","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) U1297, Institut des Maladies M\u00e9taboliques et Cardiovasculaires (I2MC), University of Toulouse , Toulouse CHU, 1 avenue Jean Poulh\u00e8s, 31 400 Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"2025082804264045800_cvaf086-B1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann Intern Med"},{"key":"2025082804264045800_cvaf086-B2","doi-asserted-by":"crossref","first-page":"109306","DOI":"10.1016\/j.steroids.2023.109306","article-title":"An overview on androgen-mediated actions in skeletal muscle and adipose tissue","volume":"199","author":"Rizk","year":"2023","journal-title":"Steroids"},{"key":"2025082804264045800_cvaf086-B3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","article-title":"Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications","volume":"97","author":"Arnal","year":"2017","journal-title":"Physiol Rev"},{"key":"2025082804264045800_cvaf086-B4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yhbeh.2015.05.024","article-title":"Hippocampal learning, memory, and neurogenesis: effects of sex and estrogens across the lifespan in adults","volume":"74","author":"Duarte-Guterman","year":"2015","journal-title":"Horm Behav"},{"key":"2025082804264045800_cvaf086-B5","doi-asserted-by":"crossref","first-page":"110741","DOI":"10.1016\/j.mce.2020.110741","article-title":"The tissue-specific effects of different 17\u03b2-estradiol doses reveal the key sensitizing role of AF1 domain in ER\u03b1 activity","volume":"505","author":"Fontaine","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"2025082804264045800_cvaf086-B6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1161\/ATVBAHA.116.307301","article-title":"Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases","volume":"37","author":"Arnold","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.122.320259","article-title":"Illuminating the mechanisms underlying sex differences in cardiovascular disease","volume":"130","author":"Reue","year":"2022","journal-title":"Circ Res"},{"key":"2025082804264045800_cvaf086-B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2042-6410-3-24","article-title":"Sex and gonadal hormones in mouse models of Alzheimer\u2019s disease: what is relevant to the human condition?","volume":"3","author":"Dubal","year":"2012","journal-title":"Biol Sex Differ"},{"key":"2025082804264045800_cvaf086-B9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0004563215610589","article-title":"Estimating age-specific trends in circulating testosterone and sex hormone-binding globulin in males and females across the lifespan","volume":"53","author":"Handelsman","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"2025082804264045800_cvaf086-B11","doi-asserted-by":"crossref","first-page":"e3348","DOI":"10.1210\/clinem\/dgaa429","article-title":"Estrone is a strong predictor of circulating estradiol in women age 70 years and older","volume":"105","author":"Davis","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B12","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1210\/jc.2018-00579","article-title":"Reproductive hormones and subclinical cardiovascular disease in midlife women","volume":"103","author":"Thurston","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B13","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1210\/jc.2010-3012","article-title":"Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the framingham heart study and applied to three geographically distinct cohorts","volume":"96","author":"Bhasin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B14","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1210\/clinem\/dgaa343","article-title":"Sex differences in 11-oxygenated androgen patterns across adulthood","volume":"105","author":"Davio","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B15","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1210\/en.2014-1890","article-title":"Measurement of a comprehensive sex steroid profile in rodent Serum by high-sensitive gas chromatography-tandem mass spectrometry","volume":"156","author":"Nilsson","year":"2015","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B16","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1523\/JNEUROSCI.3874-16.2017","article-title":"A role of endogenous progesterone in stroke cerebroprotection revealed by the neural-specific deletion of its intracellular receptors","volume":"37","author":"Zhu","year":"2017","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2025082804264045800_cvaf086-B17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/er.2017-00171","article-title":"Free testosterone: pumping up the tires or ending the free ride?","volume":"38","author":"Handelsman","year":"2017","journal-title":"Endocr Rev"},{"key":"2025082804264045800_cvaf086-B18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.steroids.2015.08.013","article-title":"Analytical challenges for measuring steroid responses to stress, neurodegeneration and injury in the central nervous system","volume":"103","author":"Schumacher","year":"2015","journal-title":"Steroids"},{"key":"2025082804264045800_cvaf086-B19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.33549\/physiolres.934124","article-title":"A method for determination of one hundred endogenous steroids in human serum by gas chromatography-tandem mass spectrometry","volume":"68","author":"Hill","year":"2019","journal-title":"Physiol Res"},{"key":"2025082804264045800_cvaf086-B20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12884-016-0937-5","article-title":"Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study","volume":"16","author":"Schock","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025082804264045800_cvaf086-B21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women","volume":"316","author":"Colditz","year":"1987","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B22","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2009.10.009","article-title":"Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?","volume":"54","author":"Matthews","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025082804264045800_cvaf086-B23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/GME.0000000000001143","article-title":"Menopause versus chronologic aging: their roles in women\u2019s health","volume":"25","author":"Thurston","year":"2018","journal-title":"Menopause N Y N"},{"key":"2025082804264045800_cvaf086-B24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-016-0762-8","article-title":"Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study","volume":"15","author":"de Kat","year":"2017","journal-title":"BMC Med"},{"key":"2025082804264045800_cvaf086-B25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/ATVBAHA.119.313622","article-title":"Arterial stiffness accelerates within 1 year of the final menstrual period: the SWAN heart study","volume":"40","author":"Samargandy","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/ije\/dyz016","article-title":"Association of menopausal characteristics and risk of coronary heart disease: a pan-European case-cohort analysis","volume":"48","author":"Dam","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2025082804264045800_cvaf086-B27","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"key":"2025082804264045800_cvaf086-B28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025082804264045800_cvaf086-B29","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0091-7435(91)90006-P","article-title":"Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence","volume":"20","author":"Stampfer","year":"1991","journal-title":"Prev Med"},{"key":"2025082804264045800_cvaf086-B31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"2025082804264045800_cvaf086-B32","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2017.16952","article-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US preventive services task force","volume":"318","author":"Gartlehner","year":"2017","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.10.005","article-title":"Effect of hormone replacement therapy on atherogenic lipid profile in postmenopausal women","volume":"184","author":"Gregersen","year":"2019","journal-title":"Thromb Res"},{"key":"2025082804264045800_cvaf086-B34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974\u20132000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil Steril"},{"key":"2025082804264045800_cvaf086-B35","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":". Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":". Conjugated equine estrogens and coronary heart disease: the Women\u2019s Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"2025082804264045800_cvaf086-B38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women\u2019s Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the women\u2019s health initiative randomized trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B41","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"2025082804264045800_cvaf086-B42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"2025082804264045800_cvaf086-B43","doi-asserted-by":"crossref","first-page":"769187","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025082804264045800_cvaf086-B44","doi-asserted-by":"crossref","first-page":"e1003731","DOI":"10.1371\/journal.pmed.1003731","article-title":"Menopausal hormone therapy and women\u2019s health: an umbrella review","volume":"18","author":"Zhang","year":"2021","journal-title":"PLoS Med"},{"key":"2025082804264045800_cvaf086-B45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/13697137.2021.2022644","article-title":"The impact of micronized progesterone on cardiovascular events - a systematic review","volume":"25","author":"Kaemmle","year":"2022","journal-title":"Climacteric J Int Menopause Soc"},{"key":"2025082804264045800_cvaf086-B46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review","volume":"25","author":"Oliver-Williams","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2025082804264045800_cvaf086-B47","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/jc.2015-2237","article-title":"Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis","volume":"100","author":"Mohammed","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B49","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"2025082804264045800_cvaf086-B50","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/STROKEAHA.116.013052","article-title":"Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen","volume":"47","author":"Canonico","year":"2016","journal-title":"Stroke"},{"key":"2025082804264045800_cvaf086-B51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B52","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":". Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B53","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"2025082804264045800_cvaf086-B54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","author":"\u201cThe 2022 Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory Panel","year":"2022","journal-title":"Menopause N Y N"},{"key":"2025082804264045800_cvaf086-B55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/GME.0b013e31829a64f9","article-title":"Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women\u2019s Health Initiative Observational Study","volume":"21","author":"Shufelt","year":"2014","journal-title":"Menopause N Y N"},{"key":"2025082804264045800_cvaf086-B56","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/eurheartj\/ehn408","article-title":"Hormone therapy and risk of myocardial infarction: a national register study","volume":"29","author":"L\u00f8kkegaard","year":"2008","journal-title":"Eur Heart J"},{"key":"2025082804264045800_cvaf086-B57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.122.061559","article-title":". Rethinking menopausal hormone therapy: for whom, what, when, and how long?","volume":"147","author":"Cho","year":"2023","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B58","doi-asserted-by":"crossref","first-page":"35539","DOI":"10.1038\/srep35539","article-title":"Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis","volume":"6","author":"Laurent","year":"2016","journal-title":"Sci Rep"},{"key":"2025082804264045800_cvaf086-B59","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1038\/s41598-018-31047-8","article-title":"Analyses of ovarian activity reveal repeated evolution of post-reproductive lifespans in toothed whales","volume":"8","author":"Ellis","year":"2018","journal-title":"Sci Rep"},{"key":"2025082804264045800_cvaf086-B60","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41586-024-07159-9","article-title":"The evolution of menopause in toothed whales","volume":"627","author":"Ellis","year":"2024","journal-title":"Nature"},{"key":"2025082804264045800_cvaf086-B61","doi-asserted-by":"crossref","first-page":"eadd5473","DOI":"10.1126\/science.add5473","article-title":"Demographic and hormonal evidence for menopause in wild chimpanzees","volume":"382","author":"Wood","year":"2023","journal-title":"Science"},{"key":"2025082804264045800_cvaf086-B62","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1016\/j.cell.2023.09.026","article-title":"Do mammals have menopause?","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"2025082804264045800_cvaf086-B63","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s43587-023-00509-8","article-title":"Female aging: when translational models don\u2019t translate","volume":"3","author":"Gilmer","year":"2023","journal-title":"Nat Aging"},{"key":"2025082804264045800_cvaf086-B64","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.89.23.11259","article-title":"Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis","volume":"89","author":"Hayashi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082804264045800_cvaf086-B65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-3565(25)24250-1","article-title":"Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit","volume":"244","author":"Gisclard","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"2025082804264045800_cvaf086-B66","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1073\/pnas.93.9.4108","article-title":"Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production","volume":"93","author":"Arnal","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082804264045800_cvaf086-B67","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0008-6363(98)00254-5","article-title":"Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production","volume":"41","author":"Barbacanne","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2025082804264045800_cvaf086-B68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/hh0402.105096","article-title":"Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor","volume":"90","author":"Darblade","year":"2002","journal-title":"Circ Res"},{"key":"2025082804264045800_cvaf086-B69","first-page":"1210","article-title":"Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor alpha agonists","volume":"51","author":"Pinna","year":"2008","journal-title":"Hypertens Dallas Tex 1979"},{"key":"2025082804264045800_cvaf086-B70","doi-asserted-by":"crossref","first-page":"e013895","DOI":"10.1161\/JAHA.119.013895","article-title":"Nuclear activation function 2 estrogen receptor \u03b1 attenuates arterial and renal alterations due to aging and hypertension in female mice","volume":"9","author":"Guivarc\u2019h","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025082804264045800_cvaf086-B71","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1038\/s41598-017-12153-5","article-title":"Estrogenic vascular effects are diminished by chronological aging","volume":"7","author":"Nicholson","year":"2017","journal-title":"Sci Rep"},{"key":"2025082804264045800_cvaf086-B72","doi-asserted-by":"crossref","first-page":"5523516","DOI":"10.1155\/2021\/5523516","article-title":"Protective effects of estrogen on cardiovascular disease mediated by oxidative stress","volume":"2021","author":"Xiang","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"2025082804264045800_cvaf086-B73","doi-asserted-by":"crossref","first-page":"e68695","DOI":"10.7554\/eLife.68695","article-title":"Membrane estrogen receptor alpha (ER\u03b1) participates in flow-mediated dilation in a ligand-independent manner","volume":"10","author":"Favre","year":"2021","journal-title":"eLife"},{"key":"2025082804264045800_cvaf086-B74","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/ijms23052862","article-title":"Early inactivation of membrane estrogen receptor alpha (ER\u03b1) recapitulates the endothelial dysfunction of aged mouse resistance arteries","volume":"23","author":"Favre","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025082804264045800_cvaf086-B75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jmb.2010.01.010","article-title":"Estrogen increases expression of the human prostacyclin receptor within the vasculature through an ERalpha-dependent mechanism","volume":"396","author":"Turner","year":"2010","journal-title":"J Mol Biol"},{"key":"2025082804264045800_cvaf086-B76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-016-0594-x","article-title":"Transition in the mechanism of flow-mediated dilation with aging and development of coronary artery disease","volume":"112","author":"Beyer","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"2025082804264045800_cvaf086-B77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0021-9150(85)90177-7","article-title":"Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas","volume":"54","author":"Fischer","year":"1985","journal-title":"Atherosclerosis"},{"key":"2025082804264045800_cvaf086-B78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1699-0463.1991.tb01250.x","article-title":"Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits","volume":"99","author":"Haarbo","year":"1991","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"2025082804264045800_cvaf086-B79","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.109.898445","article-title":"Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Billon-Gal\u00e9s","year":"2009","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B80","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/01.ATV.17.11.2679","article-title":"17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice","volume":"17","author":"Elhage","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B81","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0008-6363(01)00466-7","article-title":"Estrogen replacement therapy, atherosclerosis, and vascular function","volume":"53","author":"Mikkola","year":"2002","journal-title":"Cardiovasc Res"},{"key":"2025082804264045800_cvaf086-B82","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/gme.0b013e3182843aad","article-title":"Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future","volume":"20","author":"Clarkson","year":"2013","journal-title":"Menopause N Y N"},{"key":"2025082804264045800_cvaf086-B83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2008.01.018","article-title":"Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-\/- mice","volume":"201","author":"Cann","year":"2008","journal-title":"Atherosclerosis"},{"key":"2025082804264045800_cvaf086-B84","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0735-1097(94)90184-8","article-title":"Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys","volume":"24","author":"Williams","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2025082804264045800_cvaf086-B85","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm0397-324","article-title":"Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm","volume":"3","author":"Miyagawa","year":"1997","journal-title":"Nat Med"},{"key":"2025082804264045800_cvaf086-B86","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/01.CIR.95.7.1768","article-title":"Estradiol accelerates functional endothelial recovery after arterial injury","volume":"95","author":"Krasinski","year":"1997","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B87","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.CIR.103.3.423","article-title":"Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta","volume":"103","author":"Brouchet","year":"2001","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000050652.47145.4C","article-title":"Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor","volume":"107","author":"Gennaro","year":"2003","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B89","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1006\/jmcc.1999.0985","article-title":"Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure-prone SHHF\/Mcc- fa cp rats","volume":"31","author":"Sharkey","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"2025082804264045800_cvaf086-B90","doi-asserted-by":"crossref","first-page":"H198","DOI":"10.1152\/ajpheart.00281.2007","article-title":"Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens","volume":"294","author":"Gardner","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B91","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1113\/JP277479","article-title":"Unmasking of oestrogen-dependent changes in left ventricular structure and function in aged female rats: a potential model for pre-heart failure with preserved ejection fraction","volume":"597","author":"Bustamante","year":"2019","journal-title":"J Physiol"},{"key":"2025082804264045800_cvaf086-B92","doi-asserted-by":"crossref","first-page":"26339","DOI":"10.1074\/jbc.M414409200","article-title":"Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1","volume":"280","author":"Pedram","year":"2005","journal-title":"J Biol Chem"},{"key":"2025082804264045800_cvaf086-B93","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/hc3601.095577","article-title":"17beta-estradiol attenuates the development of pressure-overload hypertrophy","volume":"104","author":"van Eickels","year":"2001","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B94","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2020.12.102","article-title":"Differing effects of estrogen deficiency on the contractile function of atrial and ventricular myocardium","volume":"541","author":"Khokhlova","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2025082804264045800_cvaf086-B95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/gerona\/glw045","article-title":"Effect of age, estrogen Status, and late-life GPER activation on cardiac structure and function in the Fischer344\u00d7Brown Norway female rat","volume":"72","author":"Alencar","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025082804264045800_cvaf086-B96","doi-asserted-by":"crossref","first-page":"e53226","DOI":"10.1371\/journal.pone.0053226","article-title":"Carvedilol prevents ovariectomy-induced myocardial contractile dysfunction in female rat","volume":"8","author":"Ribeiro","year":"2013","journal-title":"PLoS One"},{"key":"2025082804264045800_cvaf086-B97","doi-asserted-by":"crossref","first-page":"e003456","DOI":"10.1161\/JAHA.116.003456","article-title":"Females are protected from iron-overload cardiomyopathy independent of iron metabolism: key role of oxidative stress","volume":"6","author":"Das","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025082804264045800_cvaf086-B98","doi-asserted-by":"crossref","first-page":"H811","DOI":"10.1152\/ajpheart.00980.2011","article-title":"Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype","volume":"302","author":"Lu","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B99","doi-asserted-by":"crossref","first-page":"H522","DOI":"10.1152\/ajpheart.00733.2023","article-title":"Impact of ovary-intact menopause in a mouse model of heart failure with preserved ejection fraction","volume":"326","author":"Troy","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tem.2023.03.005","article-title":"Inflammaging: mechanisms and role in the cardiac and vasculature","volume":"34","author":"Ajoolabady","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B101","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1210\/endrev\/bnac017","article-title":"Estrogen receptor signaling in the immune system","volume":"44","author":"Chakraborty","year":"2023","journal-title":"Endocr Rev"},{"key":"2025082804264045800_cvaf086-B102","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1128\/MCB.25.8.2957-2968.2005","article-title":"17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization","volume":"25","author":"Ghisletti","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2025082804264045800_cvaf086-B103","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/ATVBAHA.114.303629","article-title":"Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors","volume":"34","author":"Bowling","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B104","first-page":"21","article-title":"The influence of sex hormones and X chromosome in immune responses","volume":"441","author":"Anesi","year":"2023","journal-title":"Curr Top Microbiol Immunol"},{"key":"2025082804264045800_cvaf086-B105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","article-title":"Sex differences in metabolic regulation and diabetes susceptibility","volume":"63","author":"Tramunt","year":"2020","journal-title":"Diabetologia"},{"key":"2025082804264045800_cvaf086-B106","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jsbmb.2017.03.021","article-title":"Twenty years of the G protein-coupled estrogen receptor GPER: historical and personal perspectives","volume":"176","author":"Barton","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025082804264045800_cvaf086-B107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCULATIONAHA.118.038362","article-title":"Single-cell analysis of the normal mouse aorta reveals functionally distinct endothelial cell populations","volume":"140","author":"Kalluri","year":"2019","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B108","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm0597-545","article-title":"Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice","volume":"3","author":"Iafrati","year":"1997","journal-title":"Nat Med"},{"key":"2025082804264045800_cvaf086-B109","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1073\/pnas.042688499","article-title":"3.","volume":"99","author":"Pendaries","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082804264045800_cvaf086-B110","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.109.192849","article-title":"Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization","volume":"29","author":"Toutain","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B111","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/ATVBAHA.112.300334","article-title":"Key role of estrogens and endothelial estrogen receptor \u03b1 in blood flow-mediated remodeling of resistance arteries","volume":"33","author":"Tarhouni","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B112","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCRESAHA.115.306416","article-title":"The activation function-1 of estrogen receptor alpha prevents arterial neointima development through a direct effect on smooth muscle cells","volume":"117","author":"Smirnova","year":"2015","journal-title":"Circ Res"},{"key":"2025082804264045800_cvaf086-B113","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B114","first-page":"1906","article-title":"Estrogen receptor in the human eye: influence of gender and age on gene expression","volume":"40","author":"Ogueta","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025082804264045800_cvaf086-B115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1210\/en.2002-220749","article-title":"Colocalization and hormone regulation of estrogen receptor alpha and N-methyl-D-aspartate receptor in the hypothalamus of female rats","volume":"144","author":"Chakraborty","year":"2003","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B116","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","article-title":"CpG-rich islands and the function of DNA methylation","volume":"321","author":"Bird","year":"1986","journal-title":"Nature"},{"key":"2025082804264045800_cvaf086-B117","first-page":"2552","article-title":"Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells1","volume":"54","author":"Ottaviano","year":"1994","journal-title":"Cancer Res"},{"key":"2025082804264045800_cvaf086-B118","first-page":"2321","article-title":"Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines","volume":"56","author":"Pink","year":"1996","journal-title":"Cancer Res"},{"key":"2025082804264045800_cvaf086-B119","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0008-6363(99)00153-4","article-title":"Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system","volume":"43","author":"Post","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2025082804264045800_cvaf086-B120","first-page":"259","article-title":"Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine","volume":"16","author":"Huang","year":"2009","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"2025082804264045800_cvaf086-B121","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/01.CIR.89.4.1501","article-title":"Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women","volume":"89","author":"Losordo","year":"1994","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B122","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1210\/jc.2009-0278","article-title":"Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women","volume":"94","author":"Gavin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B123","doi-asserted-by":"crossref","first-page":"H504","DOI":"10.1152\/ajpheart.00986.2013","article-title":"Role of estrogens and age in flow-mediated outward remodeling of rat mesenteric resistance arteries","volume":"307","author":"Tarhouni","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B124","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/ATVBAHA.114.303404","article-title":"Determinants of flow-mediated outward remodeling in female rodents: respective roles of age, estrogens, and timing","volume":"34","author":"Tarhouni","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsbmb.2016.12.005","article-title":"Role of G-protein-coupled estrogen receptor (GPER\/GPR30) in maintenance of meiotic arrest in fish oocytes","volume":"167","author":"Thomas","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025082804264045800_cvaf086-B126","first-page":"1005","article-title":"GPER-novel membrane oestrogen receptor","volume":"130","author":"Zimmerman","year":"2016","journal-title":"Clin Sci Lond Engl 1979"},{"key":"2025082804264045800_cvaf086-B127","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fendo.2020.00148","article-title":"Does GPER really function as a G protein-coupled estrogen receptor in vivo?","volume":"11","author":"Luo","year":"2020","journal-title":"Front Endocrinol"},{"key":"2025082804264045800_cvaf086-B128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41422-024-00963-y","article-title":"Structural and functional evidence that GPR30 is not a direct estrogen receptor","volume":"34","author":"Liu","year":"2024","journal-title":"Cell Res"},{"key":"2025082804264045800_cvaf086-B129","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1038\/srep07564","article-title":"G protein-coupled estrogen receptor protects from atherosclerosis","volume":"4","author":"Meyer","year":"2014","journal-title":"Sci Rep"},{"key":"2025082804264045800_cvaf086-B130","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00631.2015","article-title":"GPER activation ameliorates aortic remodeling induced by salt-sensitive hypertension","volume":"310","author":"Liu","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 antagonist with improved estrogen receptor counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025082804264045800_cvaf086-B132","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat Chem Biol"},{"key":"2025082804264045800_cvaf086-B133","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.lfs.2017.06.020","article-title":"GPER agonist dilates mesenteric arteries via PI3K-akt-eNOS and potassium channels in both sexes","volume":"183","author":"Peixoto","year":"2017","journal-title":"Life Sci"},{"key":"2025082804264045800_cvaf086-B134","doi-asserted-by":"crossref","first-page":"ra105","DOI":"10.1126\/scisignal.aag0240","article-title":"Obligatory role for GPER in cardiovascular aging and disease","volume":"9","author":"Meyer","year":"2016","journal-title":"Sci Signal"},{"key":"2025082804264045800_cvaf086-B135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000478732","article-title":"GPER mediates functional endothelial aging in renal arteries","volume":"100","author":"Meyer","year":"2017","journal-title":"Pharmacology"},{"key":"2025082804264045800_cvaf086-B136","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsbmb.2017.05.006","article-title":"Role of GPER in estrogen-dependent nitric oxide formation and vasodilation","volume":"176","author":"Fredette","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025082804264045800_cvaf086-B137","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","article-title":"Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity","volume":"104","author":"Haas","year":"2009","journal-title":"Circ Res"},{"key":"2025082804264045800_cvaf086-B138","doi-asserted-by":"crossref","first-page":"170878","DOI":"10.1016\/j.peptides.2022.170878","article-title":"G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice","volume":"157","author":"Wang","year":"2022","journal-title":"Peptides"},{"key":"2025082804264045800_cvaf086-B139","doi-asserted-by":"crossref","first-page":"e48185","DOI":"10.1371\/journal.pone.0048185","article-title":"Chronic activation of the G protein-coupled receptor 30 with agonist G-1 attenuates heart failure","volume":"7","author":"Kang","year":"2012","journal-title":"PLoS One"},{"key":"2025082804264045800_cvaf086-B140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat Med"},{"key":"2025082804264045800_cvaf086-B141","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cmet.2014.05.013","article-title":"The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha","volume":"20","author":"Umetani","year":"2014","journal-title":"Cell Metab"},{"key":"2025082804264045800_cvaf086-B142","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"key":"2025082804264045800_cvaf086-B143","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.121.316883","article-title":"Single-cell RNA sequencing and assay for transposase-accessible chromatin using sequencing reveals cellular and molecular dynamics of aortic aging in mice","volume":"42","author":"Xie","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B144","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.1988.tb48855.x","article-title":"Physiology of the testosterone-binding globulin in man","volume":"538","author":"Vermeulen","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"2025082804264045800_cvaf086-B145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"2025082804264045800_cvaf086-B146","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13697137.2023.2250252","article-title":"Testosterone and the heart: friend or foe?","volume":"27","author":"Davis","year":"2024","journal-title":"Climacteric J Int Menopause Soc"},{"key":"2025082804264045800_cvaf086-B147","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","article-title":"Testosterone therapy and cardiovascular risk: advances and controversies","volume":"90","author":"Morgentaler","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2025082804264045800_cvaf086-B148","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2015.11.034","article-title":"Controversies and advances with testosterone therapy: a 40-year perspective","volume":"89","author":"Morgentaler","year":"2016","journal-title":"Urology"},{"key":"2025082804264045800_cvaf086-B149","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2017.0129","article-title":"Testosterone and male aging: faltering hope for rejuvenation","volume":"317","author":"Handelsman","year":"2017","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1506632","article-title":"Testosterone and \u2018age-related hypogonadism\u2019\u2013FDA concerns","volume":"373","author":"Nguyen","year":"2015","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B151","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B152","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.2018.7999","article-title":"Testosterone prescribing in the United States, 2002\u20132016","volume":"320","author":"Baillargeon","year":"2018","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B153","first-page":"183","article-title":"Androgen actions on endothelium functions and cardiovascular diseases","volume":"13","author":"Cai","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"2025082804264045800_cvaf086-B154","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B155","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B156","doi-asserted-by":"crossref","first-page":"H1569","DOI":"10.1152\/ajpheart.00396.2018","article-title":"Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan","volume":"315","author":"Stanhewicz","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B157","doi-asserted-by":"crossref","first-page":"970750","DOI":"10.1155\/2015\/970750","article-title":"Myocardial infarction and stroke risk in young healthy men treated with injectable testosterone","volume":"2015","author":"Tan","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2025082804264045800_cvaf086-B158","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cen.13084","article-title":"Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025082804264045800_cvaf086-B159","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"2025082804264045800_cvaf086-B160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2025082804264045800_cvaf086-B161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14656566.2024.2306832","article-title":"Testosterone replacement therapy: clinical considerations","volume":"25","author":"Luther","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"2025082804264045800_cvaf086-B162","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B163","doi-asserted-by":"crossref","first-page":"20420188221129946","DOI":"10.1177\/20420188221129946","article-title":"Menopause, androgens, and cardiovascular ageing: a narrative review","volume":"13","author":"Armeni","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B164","doi-asserted-by":"crossref","first-page":"H524","DOI":"10.1152\/ajpheart.00217.2016","article-title":"Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease","volume":"313","author":"Boese","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"2025082804264045800_cvaf086-B166","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/en.2018-00951","article-title":"Androgens ameliorate impaired ischemia-induced neovascularization due to aging in male mice","volume":"160","author":"Lam","year":"2019","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B167","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1210\/en.2010-0663","article-title":"Androgen receptor-dependent and independent atheroprotection by testosterone in male mice","volume":"151","author":"Bourghardt","year":"2010","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B168","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5551\/jat.31047","article-title":"Roles of the androgen\u2013androgen receptor system in vascular angiogenesis","volume":"23","author":"Yoshida","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"2025082804264045800_cvaf086-B169","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/ATVBAHA.117.309219","article-title":"Testosterone prevents cutaneous ischemia and necrosis in males through complementary estrogenic and androgenic actions","volume":"37","author":"Chenu","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025082804264045800_cvaf086-B170","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/JOE-14-0611","article-title":"Androgen receptor in human endothelial cells","volume":"224","author":"Torres-Estay","year":"2015","journal-title":"J Endocrinol"},{"key":"2025082804264045800_cvaf086-B171","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1161\/CIRCULATIONAHA.107.708768","article-title":"Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the tfm mouse: an effect that is independent of the classic androgen receptor","volume":"116","author":"Nettleship","year":"2007","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B172","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.arcmed.2015.11.003","article-title":"Synergistic effect of a physiological ratio of estradiol and testosterone in the treatment of early-stage atherosclerosis","volume":"46","author":"Dai","year":"2015","journal-title":"Arch Med Res"},{"key":"2025082804264045800_cvaf086-B173","first-page":"10","article-title":"Synergistic effect of estradiol and testosterone protects against IL-6-inducedcardiomyocyte apoptosismediated by TGF-\u03b21","volume":"11","author":"Xu","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"2025082804264045800_cvaf086-B174","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/molehr\/gaq049","article-title":"Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo","volume":"16","author":"Goglia","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"2025082804264045800_cvaf086-B175","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1210\/en.2009-1048","article-title":"Androgen receptor-dependent activation of endothelial nitric oxide synthase in vascular endothelial cells: role of phosphatidylinositol 3-kinase\/akt pathway","volume":"151","author":"Yu","year":"2010","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B176","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.steroids.2011.09.015","article-title":"Physiological effects of androgens on human vascular endothelial and smooth muscle cells in culture","volume":"76","author":"Nheu","year":"2011","journal-title":"Steroids"},{"key":"2025082804264045800_cvaf086-B177","doi-asserted-by":"crossref","first-page":"H1485","DOI":"10.1152\/ajpheart.00809.2013","article-title":"Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement","volume":"306","author":"Lopes","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B178","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.10.006","article-title":"The role of androgen receptors in atherosclerosis","volume":"465","author":"Takov","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"2025082804264045800_cvaf086-B179","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.91.4.1154","article-title":"Testosterone relaxes rabbit coronary arteries and aorta","volume":"91","author":"Yue","year":"1995","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B180","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.steroids.2012.05.008","article-title":"Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol","volume":"77","author":"Campelo","year":"2012","journal-title":"Steroids"},{"key":"2025082804264045800_cvaf086-B181","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.052703199","article-title":"Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis","volume":"99","author":"Mukherjee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025082804264045800_cvaf086-B182","first-page":"1540","article-title":"The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice","volume":"29","author":"Fagman","year":"2015","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"2025082804264045800_cvaf086-B183","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCULATIONAHA.113.001533","article-title":"Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling","volume":"128","author":"Yoshida","year":"2013","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B184","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1210\/en.2011-1212","article-title":"Aromatase deficiency confers paradoxical postischemic cardioprotection","volume":"152","author":"Bell","year":"2011","journal-title":"Endocrinology"},{"key":"2025082804264045800_cvaf086-B185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40618-014-0118-1","article-title":"Effects of sex hormones on inflammatory response in male and female vascular endothelial cells","volume":"37","author":"Annibalini","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"2025082804264045800_cvaf086-B186","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health"},{"key":"2025082804264045800_cvaf086-B187","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13293-020-00323-6","article-title":"Pathophysiological effects of androgens on the female vascular system","volume":"11","author":"Stone","year":"2020","journal-title":"Biol Sex Differ"},{"key":"2025082804264045800_cvaf086-B188","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4239\/wjd.v11.i3.66","article-title":"Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: a systematic review","volume":"11","author":"Spanos","year":"2020","journal-title":"World J Diabetes"},{"key":"2025082804264045800_cvaf086-B189","first-page":"383","article-title":"Metabolic effects of hormone therapy in transgender patients","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"2025082804264045800_cvaf086-B190","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/jc.2017-01643","article-title":"Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis","volume":"102","author":"Maraka","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B191","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/dc19-1061","article-title":"Effects of gender-affirming hormone therapy on insulin sensitivity and incretin responses in transgender people","volume":"43","author":"Shadid","year":"2020","journal-title":"Diabetes Care"},{"key":"2025082804264045800_cvaf086-B192","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025082804264045800_cvaf086-B193","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.118.038584","article-title":"Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy","volume":"139","author":"Nota","year":"2019","journal-title":"Circulation"},{"key":"2025082804264045800_cvaf086-B194","first-page":"1266","article-title":"Gender-affirming hormone therapy, vascular health and cardiovascular disease in transgender adults","volume":"74","author":"Connelly","year":"2019","journal-title":"Hypertens Dallas Tex 1979"},{"key":"2025082804264045800_cvaf086-B195","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/ejendo\/lvad170","article-title":"Cardiovascular disease in transgender people: a systematic review and meta-analysis","volume":"190","author":"van Zijverden","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"2025082804264045800_cvaf086-B196","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/eurjpc\/zwac133","article-title":"Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy","volume":"29","author":"Karalexi","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2025082804264045800_cvaf086-B197","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","article-title":"Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria","volume":"9","author":"de Blok","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025082804264045800_cvaf086-B198","first-page":"116","article-title":"Reversibility of testosterone-induced acyclicity after testosterone cessation in a transgender mouse model","volume":"2","author":"Kinnear","year":"2021","journal-title":"FS Sci"},{"key":"2025082804264045800_cvaf086-B199","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/humrep\/dez177","article-title":"A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men","volume":"34","author":"Kinnear","year":"2019","journal-title":"Hum Reprod Oxf Engl"},{"key":"2025082804264045800_cvaf086-B200","first-page":"189","article-title":"Short-term testosterone use in female mice does not impair fertilizability of eggs: implications for the fertility care of transgender males","volume":"36","author":"Bartels","year":"2021","journal-title":"Hum Reprod Oxf Engl"},{"key":"2025082804264045800_cvaf086-B201","doi-asserted-by":"crossref","first-page":"E540-E551","DOI":"10.1152\/ajpendo.00161.2017","article-title":"Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture","volume":"313","author":"Goetz","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B202","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/1440-1681.13495","article-title":"Cross-sex testosterone therapy modifies the renal morphology and function in female rats and might underlie increased systolic pressure","volume":"48","author":"Lichtenecker","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2025082804264045800_cvaf086-B203","doi-asserted-by":"crossref","first-page":"104839","DOI":"10.1016\/j.yhbeh.2020.104839","article-title":"Effects of adult male rat feminization treatments on brain morphology and metabolomic profile","volume":"125","author":"G\u00f3mez","year":"2020","journal-title":"Horm Behav"},{"key":"2025082804264045800_cvaf086-B204","doi-asserted-by":"crossref","first-page":"H322","DOI":"10.1152\/ajpheart.00182.2022","article-title":"Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy","volume":"323","author":"Santos","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025082804264045800_cvaf086-B205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13293-024-00586-3","article-title":"Dihydrotestosterone induces arterial stiffening in female mice","volume":"15","author":"Horton","year":"2024","journal-title":"Biol Sex Differ"},{"key":"2025082804264045800_cvaf086-B206","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jsxm.2020.05.027","article-title":"Gender-affirming hormone therapy modifies the CpG methylation pattern of the ESR1 gene promoter after six months of treatment in transmen","volume":"17","author":"Fern\u00e1ndez","year":"2020","journal-title":"J Sex Med"},{"key":"2025082804264045800_cvaf086-B207","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3390\/biomedicines10020459","article-title":"Epigenetic effects of gender-affirming hormone treatment: a pilot study of the ESR2 promoter\u2019s methylation in AFAB people","volume":"10","author":"Pallotti","year":"2022","journal-title":"Biomedicines"},{"key":"2025082804264045800_cvaf086-B208","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1210\/clinem\/dgac576","article-title":"Changes in Serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy","volume":"108","author":"Collet","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082804264045800_cvaf086-B209","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/GME.0000000000000855","article-title":"Estriol: emerging clinical benefits","volume":"24","author":"Ali","year":"2017","journal-title":"Menopause N Y N"},{"key":"2025082804264045800_cvaf086-B210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025082804264045800_cvaf086-B211","doi-asserted-by":"crossref","first-page":"e161284","DOI":"10.1172\/jci.insight.161284","article-title":"The different natural estrogens promote endothelial healing through distinct cell targets","volume":"8","author":"Davezac","year":"2023","journal-title":"JCI Insight"},{"key":"2025082804264045800_cvaf086-B212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2013.10.009","article-title":"Bazedoxifene\/conjugated estrogens for managing the burden of estrogen deficiency symptoms","volume":"77","author":"Mirkin","year":"2014","journal-title":"Maturitas"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf086\/64043915\/cvaf086.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/10\/1551\/64043915\/cvaf086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/10\/1551\/64043915\/cvaf086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:27:22Z","timestamp":1756369642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/10\/1551\/8234275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":212,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2025,8,28]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf086","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,8]]}}}